1988
DOI: 10.1001/jama.1988.03720040025021
|View full text |Cite
|
Sign up to set email alerts
|

Natural Interferon Alfa for Treatment of Condylomata Acuminata

Abstract: The activity of natural (leukocyte) interferon alfa in the treatment of condylomata acuminata was assessed in a randomized, double-blind, placebo-controlled, multicenter trial. Interferon alfa (Alferon N Injection) or placebo was injected into lesions twice weekly for up to eight weeks. Eighty-six patients were given interferon alfa, and 72 were given placebo. Eighty-six percent of interferon alfa-treated patients and 89% of placebo-treated patients had received previous therapy for condylomata acuminata. Side… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0
7

Year Published

1988
1988
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 163 publications
(35 citation statements)
references
References 13 publications
0
28
0
7
Order By: Relevance
“…Complete clearance was seen in 62% of interferon-α patients compared to 21% of placebo-treated patients. 217 Intralesional interferon-α has also been used successfully in the treatment of recurrent oral warts in AIDS patients. 218 …”
Section: Intralesional Injection Of Interferonmentioning
confidence: 99%
“…Complete clearance was seen in 62% of interferon-α patients compared to 21% of placebo-treated patients. 217 Intralesional interferon-α has also been used successfully in the treatment of recurrent oral warts in AIDS patients. 218 …”
Section: Intralesional Injection Of Interferonmentioning
confidence: 99%
“…5,6 In addition, adverse effects generally limit therapy to a maximum of 5 warts concurrently. 5,6 Because interferon is active against these warts and because imiquimod is active when applied topically, imiquimod has been examined as a potential treatment for anogenital warts with encouraging preliminary results. 7 This multicenter study compares the effectiveness and safety of 1% imiquimod cream, 5% imiquimod cream, and vehicle cream in the treatment of external anogenital warts.…”
Section: Safety Measurementsmentioning
confidence: 99%
“…However, use of this medication requires administration by multiple injections, and, although producing clearing rates of 36% to 62% without destruction of underlying skin, it is also associated with a significant recurrence rate of visible warts. 5,6 In addition, this therapy is expensive, produces systemic adverse effects, and requires multiple office visits.…”
Section: Commentmentioning
confidence: 99%
“…Тем не менее использова-ние этого способа требует множественных инъек-ций и, хотя и приводит к устранению бородавок у 36-62% без изменения нижележащих слоев кожи, но также сопровождается высокой частотой реци-дива генитальных бородавок [18,19]. Кроме того, это дорогостоящая терапия, которая сопровождает-ся системными нежелательными эффектами и тре-бует большого количества визитов в клинику.…”
Section: клинические проявления и терапия пвиunclassified
“…Однако молекула ИФН плохо всасывается. Использование ИФН или подофиллина не рекомендуется, вслед-ствие их низкой эффективности и токсичности [15][16][17][18][19].…”
Section: клинические проявления и терапия пвиunclassified